Type 2 diabetes in the young is more lethal than type 1

Flanagan, Daniel
December 2013
Diabetes Digest;2013, Vol. 12 Issue 4, p170
The article presents a study which compares the long-term clinical outcomes of people with young-onset type II diabetes (T2D) and type 1 diabetes (T1D) in Australia. The study shows that cohort had excess of complications such as increased cardiovascular disease risk factors at the last clinical visit. It reveals that cohort happened at a shorter diabetes duration from onset in regard to mortality.


Related Articles

  • The value of HbA1c for diagnosing type 2 diabetes mellitus between Chinese Uyghurs and Hans in Xinjiang. Si-Yuan Li; Si-Yao Wang; Jun Li; Kan Sun; Zhen Zhang; Guo-Lei Cao // International Journal of Clinical & Experimental Medicine;2015, Vol. 8 Issue 7, p11352 

    Objective: To compare the difference of glycosylated hemoglobin (HbA1c) for diagnosing type 2 diabetes mellitus (T2DM) between Chinese Uyghurs and Hans in xinjiang. Methods: we collected 707 subjects, including 456 Uyghurs and 251 Hans in Xinjiang Kashi region. All the subjects were underwent...

  • Revisiting screening for type 2 diabetes mellitus: the case for and against using HbA1c. Hanna, Fahmy W. F.; Wilkie, Veronica; Issa, Basil G.; Fryer, Anthony A. // British Journal of General Practice;Apr2015, Vol. 65 Issue 633, pe278 

    The article focuses on the advantages of early detection of type 2 diabetes mellitus to reduce the incidence rate of complications in Great Britain. Topics include the growing number of morbidity and premature mortality caused by type 2 diabetes mellitus, the use of oral glucose tolerance test...

  • Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes. Li, Renyuan; Xu, Wen; Luo, Sihui; Xu, Haixia; Tong, Guoyu; Zeng, Longyi; Zhu, Dalong; Weng, Jianping // Acta Diabetologica;Dec2015, Vol. 52 Issue 6, p1083 

    Aim: Preclinical studies suggested that insulin, incretin and thiazolidinediones had effect on regulation of bone metabolism. But clinical evidence is limited. We assessed the effects of these antihyperglycemic agents on bone metabolism in patients with newly diagnosed type 2 diabetes. Methods:...

  • Meta-analysis shows limited benefit of lowering blood pressure below 130/80 mm Hg in patients with type 2 diabetes. Koraishy, Farrukh M.; Peixoto, Aldo J. // Evidence Based Medicine;Dec2013, Vol. 18 Issue 6, p222 

    The authors reflect on the study titled "Intensive and standard blood pressure targets in patients with type 2 diabetes mellitus: systematic review and meta-analysis" by K. McBrien and colleagues published in a 2012 issue of the "Archives of Internal Medicine." Topics include risk of...

  • Lower risk of heart failure and stroke with exenatide than with insulin.  // Formulary;Aug2013, Vol. 48 Issue 8, p273 

    The article reports on research which was presented at the American Diabetes Association 73rd Scientific Sessions, held in June of 2013 in Chicago, Illinois. The research found that the drug dapagliflozin leads to glycemic responses in diabetic patients which are similar to those of other drugs,...

  • α-2-Macroglobulin in Saliva Is Associated with Glycemic Control in Patients with Type 2 Diabetes Mellitus. Aitken, Juan Pablo; Ortiz, Carolina; Morales-Bozo, Irene; Rojas-Alcayaga, Gonzalo; Baeza, Mauricio; Beltran, Caroll; Escobar, Alejandro // Disease Markers;3/3/2015, p1 

    Background. Subjects with type 2 diabetes mellitus (DM2) require an adequate glycemic control to avoid diabetic complications. Currently, saliva biomarkers are used as a diagnostic tool and can be indicative of the degree of progression and control of various diseases. Several studies indicate...

  • Type 2 diabetes presenting as neuropathic foot ulceration: A case report. Odunsi, Sola; Thurston, Layla; Boulton, Andrew; Bowling, Frank; Murray, David // Diabetic Foot Journal;2012, Vol. 15 Issue 1, p39 

    Classically, people with diabetes present with polydipsia, polyuria and weight loss. However, diabetes may also present with diabetic complications. Here, the authors describe a case of neuropathic foot ulceration in a man with undiagnosed diabetes. Healthcare professionals should be aware of...

  • Once-weekly exenatide is an alternative treatment to daily basal insulin.  // Formulary;Aug2013, Vol. 48 Issue 8, p274 

    The article discusses a study comparing the efficacy and tolerability of a once-weekly dose of the drug exenatide with those of daily basal insulin in patients with type 2 diabetes with baseline A1c hemoglobin of 8.5% or higher and who were taking metformin.

  • Type 2 diabetes: a case study. Cunningham, Priscilla; Noble, Helen // Nursing Standard;10/1/2014, Vol. 29 Issue 5, p37 

    Increased prevalence of diabetes in the community has been accompanied by an increase in diabetes in hospitalised patients. About a quarter of these patients experience a hypoglycaemic episode during their admission, which is associated with increased risk of mortality and length of stay. This...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics